U.S. Renewable Energy Stock News

Wondering if SiteOne Landscape Supply at around US$106.50 is starting to look interesting or still feels expensive for your portfolio? This article focuses squarely on what you are getting for the price you pay. The stock has been under pressure lately, with the share price down about 6.1% over the past week, 15.2% over the past month, 14.8% year to date, and 6.7% over the past year. These moves may change how you think about its risk and return trade off. Over the past few years, the stock...

HP (NYSE:HPQ) has introduced new AI powered PCs and developer focused systems featuring NVIDIA RTX Spark. The launch includes AI centric laptops, compact desktops, and secure workstations for creators, gamers, and AI developers. The announcement expands HP's AI product lineup with an emphasis on agentic and hybrid AI hardware environments. HP shares trade at $29.34, with the stock up 16.2% over the past week and 40.9% over the past month. Returns of 32.6% year to date and 23.7% over the...

VICI Properties (NYSE:VICI) agreed to invest $1.5b in the One Beverly Hills development, expanding its exposure to high profile real estate. The company is working on a pending acquisition of a Canadian casino portfolio, which would extend its reach into a new country. VICI also entered into a new lease agreement for MGM Northfield Park, adjusting its relationship with an existing operating partner. VICI Properties, a large experiential real estate investment company focused on gaming,...

In the past few days, American Express Global Business Travel reported quarterly revenue growth of 35.3% year on year, modestly ahead of analyst expectations, but EBITDA fell short of forecasts. This mix of stronger sales momentum and weaker profitability offers fresh insight into how the company is balancing growth investments with cost control. Next, we’ll examine how this revenue beat but EBITDA miss shapes Global Business Travel Group’s investment narrative and outlook for returns. This...

Vipshop Holdings Limited recently reported first-quarter 2026 results, with revenue of CNY 26,574.51 million and net income of CNY 2,206.31 million, alongside higher basic and diluted earnings per share compared with a year earlier. On the same day, the company issued second-quarter 2026 revenue guidance of CNY 24.5 billion to CNY 25.8 billion, signaling expectations for flat to slightly lower year-on-year sales that may prompt investors to reassess how resilient its growth drivers really...

Millicom International Cellular S.A. reported that its Annual General Meeting on May 20, 2026 approved a total dividend of US$3.00 per share, to be paid in four equal instalments on or around July 15 and October 15, 2026, and January 15 and April 15, 2027. This multi-step dividend schedule highlights management’s emphasis on steady cash returns over time, offering investors clearer visibility on upcoming income payments. We’ll now examine how this newly approved, phased US$3.00 per-share...

Recent performance and what it might signal Kenvue (KVUE) has drawn attention after mixed recent returns, with the stock roughly flat over the past month but down about 4% over the past 3 months and about 23% over the past year. At a recent close of US$17.35 and a market value of about US$33.2b, the consumer health company sits between near term share price weakness and underlying business metrics such as annual revenue of US$15.3b and net income of US$1.6b. See our latest analysis for...

agilon health stock performance snapshot agilon health (AGL) has drawn attention after a sharp move in its share price over the past month, prompting investors to reassess how its returns and financial profile line up with expectations. Over the past month, the stock shows a 2.13% return, with a 7.12% gain over the past 3 months and a 64.52% total return over the past year. Year to date, the stock is up 4.50%, while the 3 year and 5 year total returns indicate substantial declines. The...

Why Fabric.AI’s Neural I/o project matters for Kopin (KOPN) Fabric.AI’s plan to show its Neural I/o MicroLED-based optical interconnect platform by late 2026, developed with Kopin (KOPN), targets data movement constraints inside AI data centers. For Kopin, which already focuses on MicroLED display technologies and optical solutions, this collaboration places its components inside a proposed architecture that is intended to lower power use, latency, and thermal strain in hyperscale AI...

Event driven interest in Hyperliquid Strategies Hyperliquid Strategies (PURR) is drawing fresh attention after an analyst compared its trading setup to past gamma squeeze episodes, pointing to upcoming small cap index inclusion and a relatively small free float. See our latest analysis for Hyperliquid Strategies. The recent spike in speculative interest sits on top of already strong momentum, with 1-day and 7-day share price returns of 16.98% and 30.25%, and a year to date share price return...

If you are wondering whether Flowserve stock around its recent US$75.51 close still offers value, the next sections will walk through what the current price might be implying. The stock has delivered returns of 8.5% over the past 7 days, 5.4% over the last 30 days, 6.7% year to date, 54.9% over 1 year, 130.1% over 3 years and 92.4% over 5 years. This naturally raises questions about what is already priced in and how much risk you are taking on at this level. These moves are occurring...

J.B. Hunt Transport Services (NasdaqGS:JBHT) is being highlighted as a key physical infrastructure company tied to the rise of the AI-driven digital economy. Recent commentary and ETF allocations are pointing to JBHT as a logistics operator benefiting from investor interest in hard asset plays supporting data centers and cloud growth. The focus is shifting beyond earnings figures to the company’s freight network, trucking capacity, and intermodal infrastructure as critical pieces of the real...

In May 2026, ATRenew Inc. reported first-quarter 2026 results showing net income of CNY 135.09 million and basic earnings per share of CNY 0.56, issued second-quarter 2026 revenue guidance of RMB 6,240.0 million to RMB 6,340.0 million indicating year-over-year growth in the mid-twenties percent range, and updated progress on its share repurchase program. Ahead of extending its buyback plan by 12 months, ATRenew had already repurchased 2,320,482 shares for US$10.58 million, which can...

Target Hospitality Corp. (NasdaqCM:TH) recently completed a secondary offering involving more than 8,000,000 shares. The shares were sold by existing shareholders, with no new capital raised for the company. The transaction led to a significant change in Target Hospitality's shareholder structure. Target Hospitality, which operates in the specialty rental and accommodation services space, now sits in a different ownership mix after this large secondary sale. Because the shares came from...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

In late May 2026, Ituran Location and Control reported first-quarter 2026 results showing higher revenue of US$102.67 million and net income of US$16.77 million year over year, alongside a US$0.50 per-share dividend approval, an expanded US$49.00 million buyback authorization, and a broad shelf registration filing. The combination of stronger quarterly earnings with concurrent capital return measures and financing flexibility offers fresh insight into how Ituran is balancing growth...

The United States market has shown robust performance, rising 1.6% over the last week and surging 28% over the past year, with earnings forecasted to grow by 17% annually. In this environment, identifying stocks trading at significant discounts can offer potential opportunities for investors looking to capitalize on undervaluation relative to market growth expectations.

The market has climbed 1.6% in the last 7 days, contributing to a remarkable 28% increase over the past year, with earnings expected to grow by 17% per annum in the coming years. Though 'penny stock' might sound like a relic of past trading days, it still points to opportunities in smaller or newer companies that can offer significant returns when built on solid financials. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, offering...

The United States market has shown resilience with a 1.6% increase in the past week and an impressive 28% rise over the last year, supported by forecasts of annual earnings growth at 17%. In this dynamic environment, identifying promising small-cap stocks that align with these positive trends can offer unique opportunities for investors seeking to uncover potential growth stories.

The United States market has shown robust performance recently, climbing 1.6% in the last week and 28% over the past year, with earnings anticipated to grow by 17% annually. In this thriving environment, selecting dividend stocks that offer reliable income and potential for capital appreciation can be a prudent strategy for investors seeking stability and growth.

If you are wondering whether FedEx at around US$411.75 is still offering value after a strong run, the key is to look closely at what the current price implies about the company. The stock has posted returns of 4.5% over the past week, 4.6% over the past month, 40.5% year to date and 93.2% over the past year, which naturally raises questions about growth potential and how much risk is already priced in. Recent coverage has focused on FedEx as a major global logistics player, with attention...

Elmet Group recently shifted its fiscal year to a 4-4-5 calendar ending on the Friday closest to December 31, with the first such year running from January 1, 2026 to January 1, 2027, which will make several 2026 quarters not fully comparable with prior-year periods. Alongside this accounting change, Elmet’s first-quarter 2026 as a public company featured strong revenue and margin growth, a record US$113.30 million order backlog, and net IPO proceeds of about US$125.50 million used partly to...

Replimune Group, Inc. recently announced that, following collaborative discussions, it has aligned with the U.S. FDA on a prioritized resubmission and review path for its RP1 (vusolimogene oderparepvec) Biologics License Application in combination with nivolumab for patients with advanced melanoma who have progressed on prior anti-PD-1 therapy. This regulatory step is significant because RP1, an engineered herpes simplex virus designed to enhance tumor killing and immune activation, targets...